Sources referenced SELECT Semaglutide and cardiovascular outcomes in obesity without diabetes
The body metabolic rate adjusts as weight decreases, and a dose that produced robust weight loss at 280 pounds may produce slower loss at 240 pounds
Side Effects and Safety Considerations at 2.5mg The 2.5-milligram starting dose produces fewer gastrointestinal effects than higher doses, with nausea affecting roughly 20 to 30 percent of early-phase patients and typically resolving within two to three weeks
Jonsson, A., Dogan, J., Herne, N., Abrahmsn, L
As with any medical procedure, its crucial to consult with a qualified healthcare professional to determine the most suitable treatment plan based on your individual needs and circumstances
The clinical benchmark is 12 to 16 weeks on the full maintenance dose